Long-term follow-up needed after bone marrow mononuclear cell therapy for limb ischemia


Play all audios:

    

Miyamoto K et al. (2006) Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 114: 2679–2684


Therapeutic options for critical limb ischemia are limited, and patients are often unresponsive to drug therapy or unsuitable for percutaneous or surgical revascularization. Transplantation


of bone marrow mononuclear cells has previously been shown to have short-term clinical benefits for these 'no option' patients. Miyamoto et al. report on an uncontrolled, unblinded pilot


study of the long-term safety and efficacy of transplantation therapy in patients with thromboangiitis obliterans.


Anyone you share the following link with will be able to read this content: